Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by Roswell Park Cancer Institute
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Roswell Park Cancer Institute
ClinicalTrials.gov Identifier:
NCT00887432
First received: April 23, 2009
Last updated: October 11, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: October 2017 (Final data collection date for primary outcome measure)